Tower Research Capital (TRC)’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Buy
20,369
+12,091
+146% +$198K 0.01% 1300
2025
Q4
$107K Buy
8,278
+2,484
+43% +$26.3K ﹤0.01% 1900
2025
Q3
$48.9K Sell
5,794
-3,744
-39% -$35.3K ﹤0.01% 2539
2025
Q2
$82.2K Sell
9,538
-3,914
-29% -$29.1K ﹤0.01% 2543
2025
Q1
$116K Sell
13,452
-19,840
-60% -$141K ﹤0.01% 1694
2024
Q4
$223K Buy
33,292
+11,507
+53% +$85.5K ﹤0.01% 1642
2024
Q3
$157K Buy
21,785
+5,398
+33% +$49.7K ﹤0.01% 1856
2024
Q2
$170K Buy
16,387
+14,844
+962% +$148K ﹤0.01% 2196
2024
Q1
$15.5K Sell
1,543
-20,201
-93% -$217K ﹤0.01% 3236
2023
Q4
$332K Buy
21,744
+17,848
+458% +$247K ﹤0.01% 1699
2023
Q3
$54.5K Sell
3,896
-2,201
-36% -$33.3K ﹤0.01% 2476
2023
Q2
$80.7K Sell
6,097
-5,312
-47% -$72.3K ﹤0.01% 2207
2023
Q1
$184K Buy
11,409
+9,503
+499% +$168K 0.01% 1414
2022
Q4
$28K Sell
1,906
-8,739
-82% -$152K ﹤0.01% 2808
2022
Q3
$212K Buy
10,645
+205
+2% +$5.08K ﹤0.01% 1872
2022
Q2
$213K Buy
10,440
+3,256
+45% +$80.5K ﹤0.01% 1724
2022
Q1
$218K Sell
7,184
-2,487
-26% -$97.3K ﹤0.01% 1662
2021
Q4
$396K Buy
9,671
+6,261
+184% +$261K 0.01% 1275
2021
Q3
$144K Buy
3,410
+2,094
+159% +$104K ﹤0.01% 2095
2021
Q2
$69K Sell
1,316
-25,242
-95% -$1.26M ﹤0.01% 2751
2021
Q1
$1.18M Buy
26,558
+18,547
+232% +$915K 0.02% 683
2020
Q4
$385K Buy
8,011
+7,938
+10,874% +$383K 0.01% 1199
2020
Q3
$3K Sell
73
-4,065
-98% -$200K ﹤0.01% 4499
2020
Q2
$186K Sell
4,138
-278
-6% -$10.8K 0.01% 1843
2020
Q1
$129K Buy
4,416
+4,125
+1,418% +$154K 0.01% 901
2019
Q4
$14K Sell
291
-8,635
-97% -$374K ﹤0.01% 2148
2019
Q3
$338K Sell
8,926
-5,252
-37% -$205K 0.02% 754
2019
Q2
$607K Buy
14,178
+10,046
+243% +$476K 0.04% 403
2019
Q1
$219K Buy
4,132
+3,752
+987% +$215K 0.01% 1099
2018
Q4
$22K Sell
380
-835
-69% -$46.1K ﹤0.01% 1868
2018
Q3
$66K Sell
1,215
-11,139
-90% -$615K ﹤0.01% 1585
2018
Q2
$663K Buy
12,354
+7,864
+175% +$413K 0.04% 515
2018
Q1
$219K Buy
4,490
+1,722
+62% +$73.1K 0.02% 840
2017
Q4
$94K Buy
2,768
+2,224
+409% +$77.9K 0.01% 901
2017
Q3
$18K Sell
544
-126
-19% -$4.31K ﹤0.01% 2783
2017
Q2
$24K Sell
670
-270
-29% -$9.1K ﹤0.01% 1123
2017
Q1
$27K Buy
+940
New +$26.1K ﹤0.01% 1095
2016
Q4
Sell
-940
Closed -$29K 4060
2016
Q3
$29K Sell
940
-1,304
-58% -$41.2K ﹤0.01% 1407
2016
Q2
$65K Sell
2,244
-4,372
-66% -$131K 0.01% 1386
2016
Q1
$203K Buy
6,616
+5,622
+566% +$145K 0.03% 324
2015
Q4
$27K Sell
994
-2,172
-69% -$60.3K ﹤0.01% 985
2015
Q3
$86K Sell
3,166
-2,106
-40% -$57.7K 0.01% 645
2015
Q2
$145K Buy
5,272
+2,380
+82% +$57.6K 0.01% 559
2015
Q1
$62K Buy
2,892
+2,422
+515% +$41.4K 0.01% 1289
2014
Q4
$9K Sell
470
-17,108
-97% -$366K ﹤0.01% 2227
2014
Q3
$385K Buy
17,578
+9,260
+111% +$247K 0.04% 316
2014
Q2
$268K Buy
8,318
+6,766
+436% +$207K 0.03% 481
2014
Q1
$44K Buy
1,552
+1,222
+370% +$40.4K 0.01% 1189
2013
Q4
$13K Sell
330
-876
-73% -$30.4K ﹤0.01% 2738
2013
Q3
$42K Sell
1,206
-878
-42% -$27.2K ﹤0.01% 2066
2013
Q2
$47K Buy
+2,084
New +$44.4K ﹤0.01% 987

Other funds holding HLF

Tower Research Capital (TRC)'s HLF Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Herbalife (HLF) stake by 146% in Q1 2026, buying an estimated $198K and bringing the position to 20,369 shares worth $300K. The position accounts for 0.01% of the portfolio, ranked #1300.

Tower Research Capital (TRC) first reported a position in HLF in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.18M in Q1 2021. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Tower Research Capital (TRC) held 20,369 shares of Herbalife worth $300K as of Q1 2026.
  • Tower Research Capital (TRC) bought 12,091 Herbalife shares in Q1 2026, an estimated $198K.
  • Herbalife made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1300 holding.
  • Tower Research Capital (TRC) first reported a position in Herbalife in Q2 2013 and has held it in 51 quarters since.
  • Tower Research Capital (TRC)'s Herbalife position peaked at $1.18M in Q1 2021.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.